Magellan Health (MGLN) Revenue Growth Will Offset Loss of Contract
Tweet Send to a FriendGet Alerts MGLN Hot Sheet
Price: $52.40 +0.34%
Rating Summary:
3 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Rating Summary:
3 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Trade MGLN Now!
This morning Magellan Health Services, Inc. (Nasdaq: MGLN) announced a large customer signed a contract with another behavioral health manager and would not renew a contract set to expire on December 31st. The contract produced $144.5 million in revenue over the first 9-month of the year.
Commenting on developments, analysts Scott Fidel of Deutsche Bank said "the loss of this contract could create a $0.30-0.35 EPS headwind in 2014, equating to 6-7% of our prior 2014 EPS estimate of $4.75."
"However," continued Fidel, "there will still be a significant revenue growth opportunity in 2014 for MGLN from duals care coordination pilots and the Medicaid expansion and we expect MGLN to be well positioned to capitalize on these opportunities which should help offset the loss of this commercial contract."
Deutsche Bank maintained a Buy rating on Magellan Health Services with a price target of $61.00.
For an analyst ratings summary and ratings history on Magellan Health Services (Nasdaq: MGLN) click here. For more ratings news on Magellan Health Services click here.
Shares of Magellan Health Services closed at $51.75 yesterday, with a 52 week range of $40.24-$56.58.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Commenting on developments, analysts Scott Fidel of Deutsche Bank said "the loss of this contract could create a $0.30-0.35 EPS headwind in 2014, equating to 6-7% of our prior 2014 EPS estimate of $4.75."
"However," continued Fidel, "there will still be a significant revenue growth opportunity in 2014 for MGLN from duals care coordination pilots and the Medicaid expansion and we expect MGLN to be well positioned to capitalize on these opportunities which should help offset the loss of this commercial contract."
Deutsche Bank maintained a Buy rating on Magellan Health Services with a price target of $61.00.
For an analyst ratings summary and ratings history on Magellan Health Services (Nasdaq: MGLN) click here. For more ratings news on Magellan Health Services click here.
Shares of Magellan Health Services closed at $51.75 yesterday, with a 52 week range of $40.24-$56.58.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: UBS Downgrades Carnival (CCL) to Neutral; Worst May Not Be Behind
- Urban Outfitters (URBN) Added to Best Ideas List at Janney Capital on Solid Q1 Results
- UPDATE: Cantor Fitzgerald Upgrades Cubist Pharmaceuticals (CBST) to Hold
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
Deutsche Bank
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
